MIAMI (CBSMiami/CNN) — A booster dose of the Pfizer/BioNTech’s Covid-19 vaccine for youngsters ages 5 to 11 has acquired emergency use authorization from the US Food and Drug Administration so long as it’s administered not less than 5 months after completion of the first vaccine collection.
Pfizer requested this EUA on the finish of April, citing firm knowledge that confirmed {that a} third vaccine dose raised Omicron-fighting antibodies by 36 occasions on this age group.
READ MORE: US Moves To Ease Economic Sanctions Against Venezuela
“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” FDA Commissioner Dr. Robert Califf stated in a news launch Tuesday. “The FDA is authorizing the usage of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for youngsters 5 via 11 years of age to supply continued safety in opposition to COVID-19.
Studies from the New York State Department of Health and the US Centers for Disease Control and Prevention discovered that the effectiveness of two doses of Pfizer’s vaccine for youngsters ages 5 to 12 dropped considerably throughout the Omicron surge, falling from 68% to about 12% in opposition to an infection. However, two doses continued to supply safety in opposition to extra extreme sickness leading to pressing care or hospitalizations.
Public well being officers have urged Americans to remain updated with their Covid-19 vaccinations, together with all beneficial booster doses, as the easiest way to guard themselves and the folks round them.
A latest CNN evaluation of CDC knowledge confirmed that for individuals who had been totally vaccinated and boosted in February, the chance of dying from Covid-19 was 20 occasions decrease than it was for unvaccinated folks 12 and older.
READ MORE: Man’s Remains Found In Shallow Grave Behind Miami Gardens Home, Woman Arrested
The CDC’s Advisory Committee on Immunization Practices will meet Thursday to debate Covid-19 vaccine boosters. Though the agenda for the assembly has not been posted, a vote is scheduled, in keeping with the Federal Register.
Tuesday’s determination means anybody 5 and older is now eligible for not less than one booster dose.
Those who’re 50 and older and folks 12 and older who’ve sure sorts of immunocompromise are eligible for 2 booster doses.
Moderna has additionally requested FDA authorization for a second Covid-19 booster shot for everybody 18 and older, however a choice has but to be made relating to that request.
MORE NEWS: CBS4 Exclusive: Clever Thieves Using Signals From Key Fobs To Burglarize Vehicles
(©2022 CBS Broadcasting Inc. All Rights Reserved. Cable News Network, Inc., a Time Warner Company, contributed to this report.)